Skip to content
The Davies Group
The Davies Group

The Davies Group

Breaking the Rules of Chemistry

  • Home
  • Publications
  • Research Interests
    • Novel Methodologies & Mechanistic Studies
    • Catalyst Design
    • Total Synthesis & Medicinal Chemistry
  • People
    • Prof. Davies
    • Current Group Members
    • Alumni
    • Group Pictures
Posted on December 4, 2002July 12, 2018 by Davies Group

125. Tetrakis[1-[[4-dodecylphenyl]sulfonyl]-(2S)-prolinate] Dirhodium

Authors: Huw M. L. Davies

ERoS

2002

Read More

CategoriesPublications Tagschiral ligand, DOSP, Rhodium(II)

Post navigation

Previous PostPrevious 124. The Reinforcing Efficacy of the Dopamine Reuptake Inhibitor 2β-Propanoyl-3β-(4-tolyl)-tropane (PTT) as Measured by a Progressive-Ratio Schedule and a Choice Procedure in Rhesus Monkeys
Next PostNext 126. Asymmetric Intermolecular C−H Activation, Using Immobilized Dirhodium Tetrakis((S)-N-(dodecylbenzenesulfonyl)- prolinate) as a Recoverable Catalyst

CCHF Symposium [2019] – Dr. Huw Davies

https://youtu.be/TCPWeqMa-nI

Website designed by Terrence-Thang H. Nguyen

NOS Lecture [2019] – Dr. Huw Davies

https://youtu.be/3RJhsMioczA
Proudly powered by WordPress